Fisher Wallace Laboratories
Medical Devices for Mood and Sleep
Overview
Raised: $357,719
Total Commitments ($USD)
StartEngine
08/03/2022
09/01/2022
$9,999
$1,000,085
$194
Equity - Common
Seed
RegCF
$8.81
$81,236,323
Rolling Commitments ($USD)
09/30/2022
3,577%
36%
$12,335
273
2019
Fitness & Wellness
Medtech
B2B/B2C
High
High
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$4,230,290 |
$4,250,866 |
|
COGS |
$623,703 |
$970,761 |
|
Tax |
$250 |
$1,597 |
| ||
| ||
|
Net Income |
$-3,262,291 |
$-1,823,732 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$1,929,380 |
$695,749 |
|
Accounts Receivable |
$0 |
$2,302 |
|
Total Assets |
$1,999,403 |
$853,359 |
|
Short-Term Debt |
$471,468 |
$725,122 |
|
Long-Term Debt |
$576,525 |
$620,416 |
|
Total Liabilities |
$1,047,993 |
$1,345,538 |
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Fisher Wallace Laboratories | 02/24/2024 | StartEngine | $100,280,000 | $39,480 | Equity - Common | Active | RegA+ |
| Fisher Wallace | 02/20/2023 | StartEngine | $81,567,588 | $1,281,201 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 09/01/2022 | StartEngine | $81,236,323 | $357,719 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 05/27/2022 | StartEngine | $80,048,889 | $1,279,724 | Equity - Common | Funded | RegCF |
| Fisher Wallace Laboratories | 10/26/2021 | StartEngine | $40,000,000 | $5,010,683 | Equity - Common | Funded | RegA+ |
| Fisher Wallace Laboratories | 03/09/2020 | StartEngine | $15,000,000 | $1,056,480 | Equity - Common | Funded | RegCF |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Buy Fisher Wallace Laboratories's Deal Report
Warning: according to the close date for this deal, Fisher Wallace Laboratories may no longer be accepting investments.
Get KingsCrowd’s comprehensive report on Fisher Wallace Laboratories including:
- How our proprietary algorithm rates their current capital raise (1-5 stars)
- Detailed price, market, team, differentiators, performance, and risk ratings
- Whether Fisher Wallace Laboratories is undervalued or overvalued
- Scores on the founding team and key personnel's background and expertise
Buy the Fisher Wallace Laboratories deal report for only $10!
Ratings 
